login
login

Europe Daily Bulletin No. 8710

20 May 2004
Contents Publication in full By article 38 / 50
ECONOMIC INTERPENETRATION / (eu) pharmaceuticals

Belgian company, UCB (annual turnover EUR 3 bn with workforce of 11,500 will be taking over the British CELLTECH company (bio-technologies) for EUR 2.28 bn (£5.50 per ordinary share). CELLTECH's annual turnover is £350 million and it has a workforce of 1,900.

Contents

A LOOK BEHIND THE NEWS
THE DAY IN POLITICS
GENERAL NEWS
CALENDAR
ECONOMIC INTERPENETRATION